Wordt geladen...
Pazopanib for the treatment of soft-tissue sarcoma
Pazopanib is a multikinase inhibitor which potently inhibits the activity of major receptor tyrosine kinases, including vascular endothelial growth factor receptor-1, vascular endothelial growth factor receptor-2, vascular endothelial growth factor receptor-3, platelet-derived growth factor receptor...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3508654/ https://ncbi.nlm.nih.gov/pubmed/23204874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S33195 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|